JENNIFER MORRISON: Open Payments
NPI 1043234818 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,114 in 183 payments from 20 companies in 2025. Trend: 2023 $7,013 · 2024 $3,481 · 2025 $4,114
Food & beverage: $4,042Education: $71
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $868 |
| E.R. Squibb & Sons, L.L.C. | 21 | $472 |
| Axsome Therapeutics, Inc. | 12 | $419 |
| Neurocrine BioSciences, Inc. | 18 | $301 |
| Janssen Pharmaceuticals, Inc | 14 | $294 |
| ABBVIE INC. | 20 | $281 |
| Teva Pharmaceuticals USA, Inc. | 15 | $233 |
| Collegium Pharmaceutical, Inc. | 10 | $216 |
| Vanda Pharmaceuticals Inc. | 8 | $206 |
| Alkermes, Inc. | 10 | $197 |
Products named: CAPLYTA, COBENFY, Auvelity, INGREZZA, VRAYLAR, Jornay PM, FANAPT, SPRAVATO.
Industry payments across VA — which companies pay providers there.
